Interview Questions152

    The Corporate Practice of Medicine Doctrine and MSO-PC Structures

    CPOM rules prohibiting non-physician ownership, the MSO/PC two-entity model, friendly PC arrangements, state variation, and recent regulatory attention on PE/MSO structures.

    |
    7 min read
    |
    1 interview question
    |

    Introduction

    The Corporate Practice of Medicine doctrine is one of the most important structural considerations in healthcare M&A, particularly in physician practice management and PE-backed healthcare services transactions. CPOM rules exist in approximately 30+ states and prohibit non-physician entities from practicing medicine, which in practical terms means non-physician entities cannot directly employ physicians, own medical practices, or exercise control over clinical decision-making. For PE firms and corporations that want to invest in physician practices, CPOM requires a workaround structure that preserves physician ownership of the clinical entity while transferring the economic value to the non-physician investor.

    The MSO-PC Structure

    The standard workaround is the MSO-PC (Management Services Organization / Professional Corporation) model, a two-entity structure that separates the clinical practice from the management platform.

    MSO-PC Structure

    A two-entity arrangement used to navigate CPOM restrictions. The Professional Corporation (PC) is owned by a licensed physician and employs all clinical providers. The Management Services Organization (MSO) is owned by the PE firm or corporation and provides all non-clinical services (billing, revenue cycle management, HR, marketing, compliance, IT, facilities, procurement) to the PC under a long-term management services agreement (MSA). The MSO charges a management fee, typically structured as a percentage of the PC's net revenue (85-95%), that transfers substantially all of the practice's economic value to the MSO. The PC retains a small residual to cover physician compensation and direct clinical expenses. From a legal perspective, the PC maintains independent clinical control; from an economic perspective, the MSO controls the financial outcome.

    How the Economics Work

    EntityWhat It Owns/ControlsRevenue Flow
    PC (physician-owned)Clinical operations, physician employment, medical licenses, payer contractsReceives 100% of net patient revenue
    MSO (PE/corporate-owned)Non-clinical operations, real estate, equipment, IP, management systemsReceives 85-95% of PC revenue via management fee

    The management fee percentage is the central economic term. A higher percentage means more value flows to the MSO (and therefore to the PE investor). The fee must be defensible as reflecting the fair market value of the management services provided; otherwise, the arrangement may be challenged as a de facto violation of CPOM (the management fee is really a disguised payment for the right to control the medical practice) or as a violation of the Anti-Kickback Statute (the management fee is inducing referrals).

    State Variation

    CPOM rules vary dramatically by state, creating a complex compliance landscape for multi-state healthcare platforms.

    Strict CPOM states (California, New York, Texas, Illinois) prohibit non-physician corporate practice broadly and enforce the prohibition actively. MSO-PC structures are required for any PE investment in physician practices.

    Moderate CPOM states enforce CPOM selectively or have exceptions for certain specialties or practice types. Some states allow non-physician ownership of certain practices (optometry, dentistry in some jurisdictions) while prohibiting it for others.

    No CPOM states or minimal enforcement states do not restrict corporate ownership of medical practices, allowing PE firms to directly employ physicians and own practices without the MSO-PC workaround.

    MSO-PC in Deal Structures

    Acquisition Mechanics

    When a PE firm acquires a physician practice platform, it typically acquires the MSO entity (which it can own directly) and enters into a new or amended management services agreement with the PC. The PC's physician owner may receive rollover equity in the MSO as part of the transaction consideration, aligning the physician's interests with the platform's performance.

    The management services agreement is the most important document in the transaction because it defines the economic relationship between the MSO and PC. Key terms include the management fee percentage and calculation methodology, the term (typically 20-40 years with automatic renewal), the services covered (comprehensive non-clinical management), the MSO's right to approve operating budgets and capital expenditures, and the termination provisions (typically heavily restricted to protect the MSO's long-term economics).

    Management Services Agreement (MSA)

    The long-term contract between the MSO and the PC that defines the management services to be provided, the fee structure, the term, and the governance arrangement. The MSA is the legal mechanism that transfers economic value from the PC to the MSO while maintaining the PC's nominal clinical independence. MSAs are typically 20-40 years in duration with automatic renewal provisions and restrictive termination rights, designed to be effectively permanent. The MSA is the primary asset the PE firm acquires (indirectly through the MSO) in a physician practice transaction.

    Valuation Implications

    The MSO-PC structure creates unique valuation considerations. The buyer is not acquiring the medical practice itself (which it legally cannot own); it is acquiring the MSO and the right to receive management fees from the PC under the MSA. The valuation should therefore reflect the MSA's terms, the stability of the management fee, the enforceability of the contract, and the risk that regulatory changes could restrict or invalidate the MSO-PC arrangement.

    The next article covers asset vs. stock deal structures and the healthcare-specific considerations that influence this choice.

    Interview Questions

    1
    Interview Question #1Medium

    How does the corporate practice of medicine doctrine affect deal structuring in healthcare services M&A?

    In CPOM states, the acquirer (whether PE firm or corporation) cannot directly purchase and own the medical practice. This forces a dual-entity structure:

    What the buyer acquires: The MSO (Management Services Organization), which owns all non-clinical assets and provides management services under a long-term MSA. The MSO captures the economic value through management fees.

    What the buyer does NOT acquire: The PC (Professional Corporation), which remains physician-owned, employs physicians, and holds medical licenses. A "friendly physician" (often a rollover equity partner) maintains ownership of the PC.

    Deal structuring implications:

    1. MSA is the critical document. The management services agreement must be long-term (20-40 years), give the MSO substantial operational control, and ensure the management fee captures the economics the PE firm is paying for. The MSA is often more heavily negotiated than the purchase agreement itself.

    2. PC governance controls. The buyer needs contractual mechanisms to influence PC decisions (within CPOM limits): successor physician appointment rights, consent requirements for major decisions, and non-compete provisions.

    3. FMV requirements. The management fee must be defensible as fair market value under Stark Law. Above-FMV fees could be characterized as disguised referral payments.

    4. Exit complexity. The dual-entity structure must be maintained through exit, whether the exit is a secondary sale, strategic acquisition, or IPO. Each exit path has its own CPOM considerations.

    Explore More

    Networking for Investment Banking Recruiting

    A complete guide to networking for investment banking recruiting. Learn LinkedIn outreach strategies, call etiquette, and how to turn connections into interviews.

    August 10, 2025

    Investment Banking After an MBA: How Recruiting Differs

    Learn how MBA investment banking recruiting differs from undergrad. Understand the associate hiring timeline, interview process, and what banks expect from career changers.

    December 2, 2025

    PE Exit Strategies: IPO vs Sale vs Recap

    Learn the three main exit strategies for private equity firms. Compare IPO, strategic sale, and dividend recapitalization with benefits, risks, and examples.

    July 25, 2025

    Ready to Transform Your Interview Prep?

    Join 3,000+ students preparing smarter

    Join 3,000+ students who have downloaded this resource